1. Home
  2. VERI vs KALV Comparison

VERI vs KALV Comparison

Compare VERI & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veritone Inc.

VERI

Veritone Inc.

HOLD

Current Price

$5.68

Market Cap

537.1M

Sector

Technology

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$16.91

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERI
KALV
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
537.1M
551.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
VERI
KALV
Price
$5.68
$16.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$10.00
$26.43
AVG Volume (30 Days)
3.7M
1.6M
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$98,027,000.00
$1,426,000.00
Revenue This Year
$20.68
N/A
Revenue Next Year
$18.99
$204.16
P/E Ratio
N/A
N/A
Revenue Growth
0.74
N/A
52 Week Low
$1.22
$7.30
52 Week High
$9.42
$17.28

Technical Indicators

Market Signals
Indicator
VERI
KALV
Relative Strength Index (RSI) 57.06 70.46
Support Level $5.18 $15.88
Resistance Level $5.52 $17.10
Average True Range (ATR) 0.37 1.08
MACD 0.18 0.22
Stochastic Oscillator 81.11 96.52

Price Performance

Historical Comparison
VERI
KALV

About VERI Veritone Inc.

Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: